ELEVATION ONCOLOGY, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.785 USD | +6.92% |
|
+7.18% | +594.60% |
| 01:59pm | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
| 02/05 | Elevation Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Bullish |
| Resistance | 4.000 | 5.170 | 5.130 |
| Spread/Res. | -6.75% | -27.85% | -27.29% |
| Spread/Supp. | +13.72% | +150.34% | +153.74% |
| Support | 3.280 | 1.490 | 1.470 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- ELEV Stock
- Charts Elevation Oncology, Inc.
